UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

        Date of Report (date of earliest event reported): August 9, 2017


                               CEL-SCI CORPORATION
                    ---------------------------------------
             (Exact name of Registrant as specified in its charter)



         Colorado                      001-11889                84-0916344
  --------------------            ------------------       ------------------
(State or other jurisdiction     (Commission File No.)    (IRS Employer
of incorporation)                                          Identification No.)


                         8229 Boone Boulevard, Suite 802
                             Vienna, Virginia 22182
              ---------------------------------------------------
          (Address of principal executive offices, including Zip Code)



       Registrant's telephone number, including area code: (703) 506-9460



                                       N/A
              ---------------------------------------------------
          (Former name or former address if changed since last report)

<PAGE>

Item 3.03.  Material Modification to Rights of Security Holders.

     On August 9, 2017 the Company extended the expiration date of its Series DD
warrants by one month from August 10, 2017 to September 10, 2017.  The Series DD
warrants  were issued as part of a financing on December 8, 2016. As a result of
the reverse stock split  approved by the Company's  shareholders  and adopted by
the Company's  directors,  the holders of the Series DD warrants are entitled to
purchase  1,360,960 shares of the Company's common stock at an exercise price of
$4.50 per share









                                       2
<PAGE>



                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Date:  August 10, 2017                    CEL-SCI CORPORATION



                                    By: /s/ Patricia Prichep
                                        -----------------------------------
                                        Patricia Prichep
                                        Senior Vice President of Operations
[{"type": "8-K", "sequence": "1", "filename": "form8kitem303ddwar8-17.txt", "description": "8-K RE SERIES DD WARRANTS", "secsgml_size_bytes": 2628}]
{"company-data": {"conformed-name": "CEL SCI CORP", "cik": "0000725363", "assigned-sic": "2836", "irs-number": "840916344", "state-of-incorporation": "CO", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11889", "film-number": "171025434"}, "business-address": {"street1": "8229 BOONE BLVD .", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182", "phone": "7035069460"}, "mail-address": {"street1": "8229 BOONE BLVD.", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182"}, "former-company": {"former-conformed-name": "INTERLEUKIN 2 INC", "date-changed": "19880317"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

        Date of Report (date of earliest event reported): August 9, 2017

                               CEL-SCI CORPORATION
                    ---------------------------------------
             (Exact name of Registrant as specified in its charter)

         Colorado                      001-11889                84-0916344
  --------------------            ------------------       ------------------
(State or other jurisdiction     (Commission File No.)    (IRS Employer
of incorporation)                                          Identification No.)

                         8229 Boone Boulevard, Suite 802
                             Vienna, Virginia 22182
              ---------------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (703) 506-9460

                                       N/A
              ---------------------------------------------------
          (Former name or former address if changed since last report)
Item 3.03.  Material Modification to Rights of Security Holders.

     On August 9, 2017 the Company extended the expiration date of its Series DD
warrants by one month from August 10, 2017 to September 10, 2017.  The Series DD
warrants  were issued as part of a financing on December 8, 2016. As a result of
the reverse stock split  approved by the Company's  shareholders  and adopted by
the Company's  directors,  the holders of the Series DD warrants are entitled to
purchase  1,360,960 shares of the Company's common stock at an exercise price of
$4.50 per share

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date:  August 10, 2017                    CEL-SCI CORPORATION

                                    By: /s/ Patricia Prichep
                                        -----------------------------------
                                        Patricia Prichep
                                        Senior Vice President of Operations